Treatment of Choice for Varicose Veins
Endovenous thermal ablation (either radiofrequency or laser ablation) is the first-line treatment for symptomatic varicose veins with documented saphenous vein reflux in non-pregnant patients, and should not be delayed for a trial of compression therapy. 1
Treatment Algorithm by Clinical Scenario
For Non-Pregnant Patients with Symptomatic Varicose Veins
Primary truncal vein incompetence (great or small saphenous vein):
- First-line: Endovenous thermal ablation using either radiofrequency ablation (RFA) or endovenous laser ablation (EVLA) 1
- Both modalities achieve 91-100% occlusion rates at 1 year with similar efficacy 1
- These procedures are performed under local tumescent anesthesia, allow same-day discharge, and permit immediate ambulation 1
- Thermal ablation has superior quality of life outcomes and faster recovery compared to traditional surgery 1
Second-line: Ultrasound-guided foam sclerotherapy 1
- Appropriate for patients who cannot undergo thermal ablation or prefer non-thermal options 1
Third-line: Surgical ligation and stripping 1
- Reserved for cases where endovenous techniques fail or are not feasible 1
- National Institute for Health and Care Excellence guidelines explicitly downgrade surgery to third-line therapy 1
For Varicose Tributaries and Branch Veins
Concomitant treatment at time of truncal ablation:
- Phlebectomy for bulging varicosities (1-3 mm incisions to remove vein segments) 1
- Sclerotherapy for smaller vessels (1-5 mm diameter) using foam or liquid agents 1
- No evidence favors any specific sclerosant agent (hypertonic saline, sodium tetradecyl, or polidocanol) 1
For Pregnant Patients
Conservative management only:
- Compression stockings (20-30 mm Hg) as first-line therapy 1
- Defer all interventional procedures until after delivery 1
For Telangiectasias (Spider Veins)
External laser thermal ablation is most effective 1
- Hemoglobin absorbs laser light causing thermocoagulation 1
Key Evidence Supporting Thermal Ablation Superiority
Compared to traditional surgery, thermal ablation demonstrates:
- Fewer bleeding complications, hematomas, and wound infections 1
- Reduced rates of nerve injury (paresthesia) 1
- Lower rates of deep vein thrombosis (0.3%) and pulmonary embolism (0.1%) 1
- Equivalent or superior recurrence rates at 5 years (20-28% for surgery vs similar or better for EVLA) 1
Cost-effectiveness analysis:
- EVLA is most cost-effective at £16,966 per quality-adjusted life year gained versus foam sclerotherapy 2
- RFA is a close second in cost-effectiveness 2
Important Caveats and Pitfalls
Mandatory pre-treatment evaluation:
- Duplex ultrasound in the standing position is essential before any treatment to identify reflux patterns and rule out deep venous thrombosis 1
- Reflux is defined as retrograde flow >500 milliseconds in superficial veins and >1000 milliseconds in femoropopliteal veins 1
Thermal ablation risks:
- Approximately 7% risk of temporary nerve damage from thermal injury 1
- Most nerve injuries resolve spontaneously 1
Compression therapy limitations:
- Insufficient evidence supports compression as effective primary treatment for varicose veins without active ulcers 1
- Insurance may require failed compression trial before approving interventional treatment, but clinical guidelines do not support this delay 1
When compression IS indicated:
- Active venous ulcers (C6 disease): 30-40 mm Hg inelastic compression aids healing 1
- Preventing ulcer recurrence (C5 disease) after ablation 1
- Patients who refuse or cannot undergo intervention 1
Special Considerations
Perforating vein incompetence:
- Do NOT treat in simple varicose veins (C2 disease) 3
- Consider thermal ablation using transluminal occlusion of perforator (TRLOP) technique only for pathologic perforators (≥3.5 mm diameter, outward flow ≥500 ms) beneath active or healed ulcers 4, 3
Pelvic vein reflux: